Compare Immunefi (IMU) vs Sign (SIGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Sign — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Sign trades at Rp154.81 (market cap Rp369,18M, Rp73,95M 24h volume). The key difference: Sign is far larger — about 13.7× Immunefi's market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 2,4B / 10B SIGN (24%) for Sign. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Sign for 20 Days on average.
| IMU | SIGN | |
|---|---|---|
Market Cap | Rp27,03M | Rp369,18M |
Volume (24h) | Rp39,91M | Rp73,95M |
Circulating Supply | 873,4M / 10B IMU (9%) | 2,4B / 10B SIGN (24%) |
Typical Hold Time | 5 Days | 20 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
SIGN trades at Rp156.745 with a market cap of Rp374.27 million, showing neutral technical signals overall despite a bearish moving average bias. The token's circulating supply is 2.4 million out of a 10 million max, with a 24% circulation rate and average hold time of 20 days. No major protocol updates or ecosystem news were identified recently, keeping fundamental developments limited.
Outlook is cautious due to mixed technical indicators and low liquidity. Key opportunities include potential growth from increased adoption, but risks involve high volatility, limited exchange depth, and regulatory uncertainty in the crypto space. Investors should monitor support at Rp154 and resistance at Rp159 for near-term direction.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Sign
Sign is developing global infrastructure for credential verification and token distribution through two main products. The Sign Protocol is an omni-chain attestation protocol that supports digital public infrastructure for governments and serves as a foundational layer for decentralized applications. TokenTable is a smart contract-based platform that streamlines token distribution processes such as airdrops, vesting, and unlocks, allowing for seamless and transparent on-chain management.
Read more on SIGN →
